go back

Brexucabtagene Autoleucel (Tecartus)

Washington rates for HCPCS C9073

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated October 2026.

How much rates vary

Facilitymedian $380,189 · 10th to 90th $380,189 to $380,189Professionalmedian $977,237 · 10th to 90th $71 to $977,237
$100$1K$10K$100K$1Mfacility $380,189professional $977,237

Distribution of negotiated rates across all payers (price axis is log-scale). Small sample; interpret with caution. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Asuris Northwest Health
Setting
Facility
Modifier
None
Typical Low
$380,189.40
Median
$380,189.40
Typical High
$380,189.40
Asuris Northwest Health
Setting
Professional
Modifier
None
Typical Low
$977,237.22
Median
$977,237.22
Typical High
$977,237.22
Molina
Setting
Professional
Modifier
None
Typical Low
$60.26
Median
$70.79
Typical High
$79.43